Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

References

Page 1

	Year	Citations
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, New England Journal of Medicine	2005	5.9K
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Salvatore Oddo, Antonella Caccamo, Jason D. Shepherd, Neuron Alzheimer's DiseaseDementiaDegenerative DiseaseNeurochemical BiomarkersTriple-transgenic Model	2003	4.1K
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. Alfred H. Schinkel, Els Wagenaar, Carla A.A.M. Mol, Journal of Clinical Investigation Oral LoperamideBrain PenetrationPharmacotherapyExperimental PharmacologySocial Sciences	1996	1.3K
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease Lon S. Schneider, Pierre N. Tariot, Karen Dagerman, New England Journal of Medicine	2006	1.2K
Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors Yasuo Uchida, Sumio Ohtsuki, Yuki Katsukura, Journal of Neurochemistry Human Bbb FunctionNeurochemical BiomarkersPeptide ScienceProteomic TechnologyMolecular Pharmacology	2011	891
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011 Christoph Hiemke, Pierre Baumann, N. Bergemann, Pharmacopsychiatry Psychiatric EvaluationPsychopharmacologyTdm Expert GroupPharmacotherapySocial Sciences	2011	851
The hCMEC/D3 cell line as a model of the human blood brain barrier Babette B. Weksler, Ignacio A. Romero, Pierre‐Olivier Couraud Fluids and Barriers of the CNS	2013	752
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease Harm J. van de Haar, Saartje Burgmans, Jacobus F.A. Jansen, Radiology	2016	599
Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene Roberto Montesano, Michael S. Pepper, Uta Möhle-Steinlein, Cell Endothelial Cell PathobiologyDevelopmental BiologyAngiogenesisSignal TransductionEndothelial Cells	1990	454
Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity H. Schoemaker, Y. Claustre, Dominique Fage, Journal of Pharmacology and Experimental Therapeutics	1997	372

Page 1